Opinion/Hypothesis | Therapeutics and Prevention

Questionable Efficacy of Therapeutic Antibodies in the Treatment of Anthrax

Jean-Nicolas Tournier, Clémence Rougeaux, Fabrice V. Biot, Pierre L. Goossens
Patricia A. Bradford, Editor
DOI: 10.1128/mSphere.00282-19

Article Information

DOI 
https://doi.org/10.1128/mSphere.00282-19
PubMed 
31217301
Published By 
American Society for Microbiology Journals
History 
  • Published online June 19, 2019.
Copyright & Usage 
Copyright © 2019 Tournier et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.
Editors and / or Reviewers 
  • Patricia A. Bradford, Editor, Antimicrobial Development Specialists, LLC

Author Information

  1. Jean-Nicolas Tourniera,b,c,d,
  2. Clémence Rougeauxa,
  3. Fabrice V. Biota,c and
  4. Pierre L. Goossensa,e
  1. aInstitut de Recherche Biomédicale des Armées, Bacteriology, Anti-infectious Biotherapies, and Immunity Unit, Brétigny-sur-Orge, France
  2. bInstitut Pasteur, Viral Genomics and Vaccination Unit, CNRS UMR-3569, Paris, France
  3. cNational Reference Center for Anthrax (CNR-LE Charbon), Brétigny-sur-Orge, France
  4. dEcole du Val-de-Grâce, Paris, France
  5. eInstitut Pasteur, Yersinia Unit, Paris, France
  • Address correspondence to Jean-Nicolas Tournier, jntournier.irba{at}gmail.com.

  • Citation Tournier J-N, Rougeaux C, Biot FV, Goossens PL. 2019. Questionable efficacy of therapeutic antibodies in the treatment of anthrax. mSphere 4:e00282-19. https://doi.org/10.1128/mSphere.00282-19.

View Abstract

Article usage

Article usage: June 2019 to June 2020

Rendering graph...
AbstractFullPdf
Jun 20193918483
Jul 201947531
Aug 2019122819
Sep 201942617
Oct 201912412
Nov 201934018
Dec 20191267
Jan 20207359
Feb 202013820
Mar 202003112
Apr 202065023
May 202025511
Jun 2020020
Back to top
Download PDF
Citation Tools
Print
Alerts
Email

KEYWORDS

anthrax
antitoxins
monoclonal antibodies
protective antigen
toxins

Related Articles

Cited By...